Since activated RTK and PI3K signaling was a common motif in CDK2 inhibitor-resistant ovarian cancer cells, we next tested the hypothesis that constitutively active RTK signaling could confer resistance to CDK2 inhibition. Here, PIK3CA is linked to ovarian carcinoma.